Gardner Lewis Asset Management L P Repligen Corp Transaction History

Gardner Lewis Asset Management L P

  • $353 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$161.19 - $257.96 $575,931 - $921,691
-3,573 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$247.59 - $304.47 $884,639 - $1.09 Million
3,573 New
3,573 $946,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Gardner Lewis Asset Management L P Portfolio

Follow Gardner Lewis Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Lewis Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email